Finding 370815 (2021-003)

Significant Deficiency
Requirement
ABC
Questioned Costs
-
Year
2021
Accepted
2024-02-27

AI Summary

  • Core Issue: There is a significant weakness in internal controls over cash disbursements, as procedures for purchase orders and check requests were not consistently followed.
  • Impacted Requirements: Strong internal controls mandate authorization and approval for all non-payroll cash disbursements, which were not always adhered to.
  • Recommended Follow-Up: Ensure all non-payroll purchases have a purchase order and/or check request; the organization is implementing a new system to improve compliance.

Finding Text

Type of finding: Significant weakness in Internal Controls over cash disbursements. Condition: The Organization’s internal controls require a purchase order and or a check request for all non-payroll cash disbursements. When testing cash disbursements, it was noted this procedure was not always followed; however they did have an overriding control of review of bill, and allowability to budget before any checks were signed. Criteria: Strong internal controls requires authorization and approval of all purchases made by the Organization. Context: The Organization’s internal controls require authorization and approval for all non-payroll cash disbursements but they were not always followed. Cause Not following all the authorization and approval could allow an improper payment to be made. Recommendation: Require all non-payroll purchases to have a purchase order and/or a check request. Planned corrective actions: The Organization had implemented a new purchase order system and have simplified the check requests to make it easier to follow and will use for all non payroll, and non reoccurring purchases.

Corrective Action Plan

Description of Finding: Significant weakness in Internal Controls over cash disbursements. DCSOS has an internal policy which requires purchase order and/or a check request be issued for all non-payroll cash disbursements. Having these internal controls in place ensures payments are made correctly. Statement of Concurrence or Nonconcurrence: Strong internal controls require authorization and approval of all purchases made by the Organization. In some instances, these procedures were not always followed, however there is an overriding control of review of bill and budget allowability before payment was issued. DCSOS agrees with the audit finding. Corrective Action: For all non-payroll purchases a new purchase order and/or check request form must be developed to include budget allocation and all future invoices will follow this approval process. Proposed Completion Date: Immediate Person Responsible for Corrective Action: Financial Officer

Categories

Procurement, Suspension & Debarment Internal Control / Segregation of Duties

Other Findings in this Audit

  • 370813 2021-001
    Significant Deficiency
  • 370814 2021-002
    Significant Deficiency
  • 370816 2021-004
    Significant Deficiency
  • 370817 2021-001
    Significant Deficiency
  • 370818 2021-002
    Significant Deficiency
  • 370819 2021-003
    Significant Deficiency
  • 370820 2021-004
    Significant Deficiency
  • 370821 2021-001
    Significant Deficiency
  • 370822 2021-002
    Significant Deficiency
  • 370823 2021-003
    Significant Deficiency
  • 370824 2021-004
    Significant Deficiency
  • 370825 2021-001
    Significant Deficiency
  • 370826 2021-002
    Significant Deficiency
  • 370827 2021-003
    Significant Deficiency
  • 370828 2021-004
    Significant Deficiency
  • 370829 2021-001
    Significant Deficiency
  • 370830 2021-002
    Significant Deficiency
  • 370831 2021-003
    Significant Deficiency
  • 370832 2021-004
    Significant Deficiency
  • 370833 2021-001
    Significant Deficiency
  • 370834 2021-002
    Significant Deficiency
  • 370835 2021-003
    Significant Deficiency
  • 370836 2021-004
    Significant Deficiency
  • 370837 2021-001
    Significant Deficiency
  • 370838 2021-002
    Significant Deficiency
  • 370839 2021-003
    Significant Deficiency
  • 370840 2021-004
    Significant Deficiency
  • 370841 2021-001
    Significant Deficiency
  • 370842 2021-002
    Significant Deficiency
  • 370843 2021-003
    Significant Deficiency
  • 370844 2021-004
    Significant Deficiency
  • 370845 2021-001
    Significant Deficiency
  • 370846 2021-002
    Significant Deficiency
  • 370847 2021-003
    Significant Deficiency
  • 370848 2021-004
    Significant Deficiency
  • 947255 2021-001
    Significant Deficiency
  • 947256 2021-002
    Significant Deficiency
  • 947257 2021-003
    Significant Deficiency
  • 947258 2021-004
    Significant Deficiency
  • 947259 2021-001
    Significant Deficiency
  • 947260 2021-002
    Significant Deficiency
  • 947261 2021-003
    Significant Deficiency
  • 947262 2021-004
    Significant Deficiency
  • 947263 2021-001
    Significant Deficiency
  • 947264 2021-002
    Significant Deficiency
  • 947265 2021-003
    Significant Deficiency
  • 947266 2021-004
    Significant Deficiency
  • 947267 2021-001
    Significant Deficiency
  • 947268 2021-002
    Significant Deficiency
  • 947269 2021-003
    Significant Deficiency
  • 947270 2021-004
    Significant Deficiency
  • 947271 2021-001
    Significant Deficiency
  • 947272 2021-002
    Significant Deficiency
  • 947273 2021-003
    Significant Deficiency
  • 947274 2021-004
    Significant Deficiency
  • 947275 2021-001
    Significant Deficiency
  • 947276 2021-002
    Significant Deficiency
  • 947277 2021-003
    Significant Deficiency
  • 947278 2021-004
    Significant Deficiency
  • 947279 2021-001
    Significant Deficiency
  • 947280 2021-002
    Significant Deficiency
  • 947281 2021-003
    Significant Deficiency
  • 947282 2021-004
    Significant Deficiency
  • 947283 2021-001
    Significant Deficiency
  • 947284 2021-002
    Significant Deficiency
  • 947285 2021-003
    Significant Deficiency
  • 947286 2021-004
    Significant Deficiency
  • 947287 2021-001
    Significant Deficiency
  • 947288 2021-002
    Significant Deficiency
  • 947289 2021-003
    Significant Deficiency
  • 947290 2021-004
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
17.259 Wia Youth Activities $205,225
17.258 Wia Adult Program $122,083
93.276 Drug-Free Communities Support Program Grants $121,715
16.540 Juvenile Justice and Delinquency Prevention_allocation to States $70,005
93.788 Opioid Str $46,453
93.243 Substance Abuse and Mental Health Services_projects of Regional and National Significance $35,622
93.558 Temporary Assistance for Needy Families $31,365